This series of three educational webinars will cover the latest developments in the precision medicine landscape in non-small cell lung cancer (NSCLC) and focus on the key role of next-generation sequencing (NGS)-based biomarker profiling. Oncologists, pathologists, and geneticists will summarise the necessities, possibilities, and future trends in NSCLC biomarker profiling, and share their own experiences with optimising the testing process and its integration in multidisciplinary patient care. The webinar will include time for questions and discussions.
Join our experts Diego Cortinovis, Fabio Pagni, Nicola Normanno (Italy) and Bence Sipos (Germany)
Sign up to all three webinars below:
Overview of Precision Therapy Landscape in NSCLC and the Importance of Rapid Biomarker Profiling Results (Part 1 of 3)
Tue, Sep 24, 2024 4:00 PM – 5:00 PM BST
NGS testing for precision oncology in Europe: Updated ESMO guidelines and latest developments (Part 2 of 3)
Thu, Nov 07, 2024 5:00 PM – 6:00 PM BST
Integrating Latest Precision Oncology Development’s and Insights in Daily Management of NSCLC Patients: Round table discussion between MDT members (Part 3 of 3)
TBC
